Abbott Laboratories buy Citigroup Inc.
Start price
03.04.24
/
50%
€103.10
Target price
03.04.25
€118.21
Performance (%)
-5.60%
Price
29.07.24
€96.81
Summary
This prediction is currently active. With a performance of -5.60%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 03.04.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 3.326% | 3.326% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $126.00 to $128.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€96.77
22.05.24
22.05.24
€109.79
22.05.25
22.05.25
0.04%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.48
25.01.24
25.01.24
€116.25
25.01.25
25.01.25
-5.03%
29.07.24
29.07.24